SIAMAB THERAPEUTICS INC has a total of 36 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are KOLLTAN PHARMACEUTICALS INC, THROMGEN INC and EPSTEIN ALAN L.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 11 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 2 | |
#5 | Israel | 2 | |
#6 | Mexico | 2 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Sugars | |
#6 | Combinatorial chemistry | |
#7 | Foods | |
#8 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Behrens Jeffrey | 27 |
#2 | Ghaderi Darius | 17 |
#3 | Eavarone David A | 17 |
#4 | Prendergast Jillian M | 16 |
#5 | Da Silva Ana Paula Galvao | 14 |
#6 | Desander Julie | 14 |
#7 | Zhang Mai | 14 |
#8 | Lugovskoy Alexey Alexandrovich | 13 |
#9 | Dransfield Daniel T | 8 |
#10 | Meetze Kristan | 6 |
Publication | Filing date | Title |
---|---|---|
US2019276541A1 | Glycan-interacting compounds and methods of use | |
WO2018094143A1 | Glycan-interacting compounds and methods of use | |
WO2017132486A1 | Compositions and methods for targeting cancer stem cells | |
CN108463248A | Glycan interacting compounds and application method | |
WO2016201240A1 | Compositions and methods for targeting cancer stem cells | |
US2016130356A1 | Glycan-interacting compounds and methods of use | |
EP3218005A1 | Glycan-interacting compounds and methods of use | |
WO2016057916A1 | Glycan-interacting compounds and methods of use | |
WO2016057890A1 | Glycan analysis and profiling | |
EP3054974A2 | Glycan-interacting compounds and methods of use | |
WO2014194053A2 | Carbohydrate compounds for nutritional and therapeutic use | |
US2014178365A1 | Glycan-interacting compounds |